Education
About Us
Working with TipRanks
Follow Us
Stoke Therapeutics Inc (DE:0GT)
FRANKFURT:0GT
RESEARCH TOOLSreports
Stoke Therapeutics (0GT) Ownership Overview
45.88% Insiders
10.36%
Mutual Funds
2.57% Other Institutional Investors
10.99% ETFs
30.20% Public Companies and Individual Investors
The ownership structure of Stoke Therapeutics (DE:0GT) stock is a mix of institutional, retail, and individual investors. Approximately 23.92% of the company’s stock is owned by Institutional Investors, 45.88% is owned by Insiders, and 30.20% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 20, 2025 | xxxxxxxxxxxxx | $61238 | |
Mar 20, 2025 | xxxxxxxxxxxxx | $35731 | |
Mar 20, 2025 | xxxxxxxxxxxxx | $163673 | |
Dec 27, 2024 | xxxxxxxxxxxxx | $23000000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $239978 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $632548 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $703683 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,161,713 | Insider | 31.43% | 161,955,086 | |
| 6,906,181 | Insider | 12.65% | 65,173,630 | |
| 4,633,838 | Institution | 8.49% | 43,729,529 | |
| 2,510,964 | Institution | 4.60% | 23,695,967 | |
| 2,166,300 | Institution | 3.97% | 20,443,373 | |
| 1,767,653 | Institution | 3.24% | 16,681,341 | |
| 925,936 | Institution | 1.70% | 8,738,058 | |
| 832,030 | Institution | 1.52% | 7,851,867 | |
| 399,194 | Institution | 0.73% | 3,767,194 | |
| 383,000 | Institution | 0.70% | 3,614,371 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,166,300 | Institution | 3.97% | 20,443,373 | |
| 925,936 | Institution | 1.70% | 8,738,058 | |
| 399,194 | Institution | 0.73% | 3,767,194 | |
| 383,000 | Institution | 0.70% | 3,614,371 | |
| 201,596 | Institution | 0.37% | 1,902,461 | |
| 151,992 | Institution | 0.28% | 1,434,349 | |
| 145,046 | Institution | 0.27% | 1,368,799 | |
| 141,688 | Institution | 0.26% | 1,337,110 | |
| 129,031 | Institution | 0.24% | 1,217,666 | |
| 108,857 | Institution | 0.20% | 1,027,284 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Stoke Therapeutics Inc (DE:0GT)?
According to the latest TipRanks data, approximately 2.57% of the company's stock is held by institutional investors, 45.88% is held by insiders, and 30.20% is held by retail investors.
What percentage of Stoke Therapeutics Inc (DE:0GT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.57% of Stoke Therapeutics Inc (DE:0GT) stock is held by institutional investors.
What percentage of Stoke Therapeutics Inc (DE:0GT) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.20% of Stoke Therapeutics Inc (DE:0GT) stock is held by retail investors.
Who owns the most shares of Stoke Therapeutics Inc (DE:0GT)?
Seth Loring Harrison owns the most shares of Stoke Therapeutics Inc (DE:0GT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.